Categories: News

Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference. Details are as follows:

Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
Date: Thursday, June 10
Time: 3:00 PM ET

A live webcast of the virtual fireside chat will be available on the Investors & Media section of the Codiak website at www.codiakbio.com. An archived replay will be available for approximately 30 days following the fireside chat.

About Codiak BioSciences
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx™ Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.

CONTACT: Investor Contact:
Christopher Taylor
VP, Investor Relations and Corporate Communications
T: 617-949-4220
E: investor@codiakbio.com

Media Contact:
Lindy Devereux
Scient PR
T: 646-515-5730
E: media@codiakbio.com

Staff

Recent Posts

Danziger & De Llano Launches New Website to Better Serve Victims of Mesothelioma and Personal Injury

HOUSTON, May 30, 2025 /PRNewswire/ -- Danziger & De Llano, LLP, a Texas-based law firm with…

3 hours ago

AIxMed Partnership with Lumea Enhances Digital Pathology Platform with AI-Powered Urine Cytology Solution

Lumea and AIxMed team up to bring AI driven urine cytology to Lumea's platform, targeting…

3 hours ago

Real-World Deployments Signal AI Healthcare Is Ready for Scale

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 30,…

3 hours ago

The National Hispanic Health Foundation Begins a Bold New Chapter to Build a Sustainable Healthcare System for All

WASHINGTON, May 30, 2025 /PRNewswire/ -- The National Hispanic Health Foundation (NHHF), formerly part of the…

3 hours ago

Velsera Powers the Knowledgebase Behind Illumina’s TSO Comprehensive Test, Now Approved in Japan

BOSTON, May 30, 2025 /PRNewswire/ -- Velsera announces that its clinical Knowledgebase is powering the interpretation…

3 hours ago